The Journal of Practical Medicine >
Progress in prevention and treatment of arteriovenous fistula dysfunction
Received date: 2023-11-12
Online published: 2024-07-09
Arteriovenous fistula dysfunction （AVF） is a frequent and often unforeseeable complication in hemodialysis patients， and the most common cause is venous outflow stenosis resulting from neointimal hyperplasia and outward remodeling. Currently， there have been few effective prevention and treatment measures for AVF， therefore， this paper reviews the interventions and preventive measures of the AVF.
Key words： hemodialysis; arteriovenous fistula; dysfunction; prevention and treatment; progress
Feng ZHANG , Hongying. JIANG . Progress in prevention and treatment of arteriovenous fistula dysfunction[J]. The Journal of Practical Medicine, 2024 , 40(13) : 1767 -1770 . DOI: 10.3969/j.issn.1006-5725.2024.13.001
| 1 | SUN C Y， MO Y W， LAN L J， et al. It is time to implement prepump arterial pressure monitoring during hemodialysis： A retrospective multicenter study［J］. J Vasc Access， 2020，21（6）：938-944. doi:10.1177/1129729820917266 |
| 2 | 中国医院协会血液净化中心分会血管通路工作组. 中国血液透析用血管通路专家共识（第2版）［J］. 中国血液净化，2019，18（6）：365-381. doi:10.3969/j.issn.1671-4091.2019.06.001 |
| 3 | MACASKILL M G， WATSON D G， EWART M A， et al. Improving arteriovenous fistula patency： Transdermal delivery of diclofenac reduces cannulation-dependent neointimal hyperplasia via AMPK activation［J］. Vascul Pharmacol， 2015，71：108-115. doi:10.1016/j.vph.2015.02.012 |
| 4 | BILGIC M A， YILMAZ H， BOZKURT A， et al. Relationship of late arteriovenous fistula stenosis with soluble E-selectin and soluble EPCR in chronic hemodialysis patients with arteriovenous fistula［J］. Clin Exp Nephrol， 2015，19（1）：133-139. doi:10.1007/s10157-014-0955-4 |
| 5 | WANG F， YANG C， LONG J， et al. Executive summary for the 2015 Annual Data Report of the China Kidney Disease Network （CK-NET）［J］. Kidney Int， 2019，95（3）：501-505. doi:10.1016/j.kint.2018.11.011 |
| 6 | 王耿， 陈志强， 李孝虎，等. 高压球囊对比普通球囊治疗自体动静脉内瘘狭窄疗效的前瞻性分析［J］. 中国血管外科杂志（电子版）， 2016，8（1）：53-56. doi:10.3969/j.issn.1674-7429.2016.01.014 |
| 7 | TREROTOLA S O， KWAK A， CLARK T W， et al. Prospective study of balloon inflation pressures and other technical aspects of hemodialysis access angioplasty［J］. J Vasc Interv Radiol， 2005，16（12）：1613-1618. doi:10.1097/01.rvi.0000183588.57568.36 |
| 8 | 李越， 王兵， 牛晓阳，等. 药物涂层球囊在自体动静脉瘘狭窄治疗中的应用［J］. 实用医学杂志， 2023，39（6）：724-729. doi:10.3969/j.issn.1006-5725.2023.06.012 |
| 9 | TREROTOLA S O， LAWSON J， ROY-CHAUDHURY P， et al. Drug Coated Balloon Angioplasty in Failing AV Fistulas： A Randomized Controlled Trial［J］. Clin J Am Soc Nephrol， 2018，13（8）：1215-1224. doi:10.2215/cjn.14231217 |
| 10 | ABDUL SALIM S， TRAN H， THONGPRAYOON C， et al. Comparison of drug-coated balloon angioplasty versus conventional angioplasty for arteriovenous fistula stenosis： Systematic review and meta-analysis［J］. J Vasc Access， 2020，21（3）：357-365. doi:10.1177/1129729819878612 |
| 11 | MURAKAMI M， FURUSHIMA D， HAMAMOTO S， et al. Comparison of peripheral cutting balloon angioplasty with conventional balloon angioplasty for recurrent hemodialysis vascular access stenosis： A prospective randomized controlled trial［J］. J Vasc Access， 2023：11297298231209489. doi:10.1177/11297298231209489 |
| 12 | 陈佳佺， 倪其泓， 朱经谱，等. 切割球囊扩张治疗自体动静脉内瘘复发性狭窄的临床疗效［J］. 介入放射学杂志， 2023，32（6）：565-568. doi:10.3969/j.issn.1008-794X.2023.06.009 |
| 13 | GüR S， O?UZKURT L， GEDIKO?LU M. Central venous occlusion in hemodialysis access： Comparison between percutaneous transluminal angioplasty alone and nitinol or stainless-steel stent placement［J］. Diagn Interv Imaging， 2019，100（9）：485-492. doi:10.1016/j.diii.2019.03.011 |
| 14 | PINELO A， ALMEIDA P， LOUREIRO L， et al. Use of a Paclitaxel Drug-Eluting Stent for the Treatment of Hemodialysis Access Outflow Stenosis［J］. J Vasc Interv Radiol， 2024，35（3）：384-389. doi:10.1016/j.jvir.2023.11.010 |
| 15 | MCCASLIN J E， ANDRAS A， STANSBY G. Cryoplasty for peripheral arterial disease［J］. Cochrane Database Syst Rev， 2013（8）：CD005507. |
| 16 | ZHOU Y， ZHANG Z， LIN S， et al. Comparative Effectiveness of Endovascular Treatment Modalities for De Novo Femoropopliteal Lesions： A Network Meta-analysis of Randomized Controlled Trials［J］. J Endovasc Ther， 2020，27（1）：42-59. doi:10.1177/1526602819895996 |
| 17 | RIFKIN B S， BREWSTER U C， ARUNY J E， et al. Percutaneous balloon cryoplasty： a new therapy for rapidly recurrent anastomotic venous stenoses of hemodialysis grafts？［J］. Am J Kidney Dis， 2005，45（2）：e27-e32. doi:10.1053/j.ajkd.2004.11.001 |
| 18 | GRAY R J， VARMA J D， CHO S S， et al. Pilot study of cryoplasty with use of PolarCath peripheral balloon catheter system for dialysis access［J］. J Vasc Interv Radiol， 2008，19（10）：1460-1466. doi:10.1016/j.jvir.2008.06.010 |
| 19 | 王琬婧， 刘晓雯， 刘瑶. 远红外线干预应用于自体动静脉内瘘护理的研究进展［J］. 医疗装备， 2021，34（23）：194-196. doi:10.3969/j.issn.1002-2376.2021.23.090 |
| 20 | HUANG J， ZHENG P， CHEN X， et al. Effect of far-infrared therapy device on arteriovenous fistula maturation and lifespan in hemodialysis patients： a randomized controlled clinical trial［J］. Front Surg， 2023，10：1260979. doi:10.3389/fsurg.2023.1260979 |
| 21 | HADIMERI U， W?RME A， STEGMAYR B. A single treatment， using Far Infrared light improves blood flow conditions in arteriovenous fistula［J］. Clin Hemorheol Microcirc， 2017，66（3）：211-217. doi:10.3233/ch-170254 |
| 22 | LINDHARD K， RIX M， HEAF J G， et al. Effect of far infrared therapy on arteriovenous fistula maturation， survival and stenosis in hemodialysis patients， a randomized， controlled clinical trial： the FAITH on fistula trial［J］. BMC Nephrol， 2021，22（1）：283. doi:10.1186/s12882-021-02476-x |
| 23 | GALLIENI M， HOLLENBECK M， INSTON N， et al. Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults［J］. Nephrol Dial Transplant， 2020，35（10）：1824. doi:10.1093/ndt/gfz153 |
| 24 | PALMER S C， DI MICCO L， RAZAVIAN M， et al. Antiplatelet therapy to prevent hemodialysis vascular access failure： systematic review and meta-analysis［J］. Am J Kidney Dis， 2013，61（1）：112-122. doi:10.1053/j.ajkd.2012.08.031 |
| 25 | JACKSON A J， COATS P， KINGSMORE D B. Pharmacotherapy to improve outcomes in vascular access surgery： a review of current treatment strategies［J］. Nephrol Dial Transplant， 2012，27（5）：2005-2016. doi:10.1093/ndt/gfr552 |
| 26 | CLAIR D M M， BURGESS J E A. Arteriovenous Fis tula Outcomes After Local Vascular Delivery of a Siro limus Formulation［J］. Vasc Surg， 2019，70（2）：e37-e38. doi:10.1016/j.jvs.2019.06.048 |
| 27 | YANG B， BRAHMBHATT A， NIEVES TORRES E， et al. Tracking and Therapeutic Value of Human Adipose Tissue-derived Mesenchymal Stem Cell Transplantation in Reducing Venous Neointimal Hyperplasia Associated with Arteriovenous Fistula［J］. Radiology， 2016，279（2）：513-522. doi:10.1148/radiol.2015150947 |
| 28 | URBICH C， DIMMELER S. Endothelial progenitor cells： characterization and role in vascular biology［J］. Circ Res， 2004，95（4）：343-353. doi:10.1161/01.res.0000137877.89448.78 |
| 29 | HUANG X， GUAN J， SHENG Z， et al. Effect of local anti-vascular endothelial growth factor therapy to prevent the formation of stenosis in outflow vein in arteriovenous fistula［J］. J Transl Int Med， 2021，9（4）：307-317. doi:10.2478/jtim-2021-0045 |
| 30 | YANG B， JANARDHANAN R， VOHRA P， et al. Adventitial transduction of lentivirus-shRNA-VEGF-A in arteriovenous fistula reduces venous stenosis formation［J］. Kidney Int， 2014，85（2）：289-306. doi:10.1038/ki.2013.290 |
| 31 | 谢筱彤， 刘宏， 涂岩，等. 维持性血液透析患者动静脉内瘘功能不良的影响因素［J］. 肾脏病与透析肾移植杂志， 2018，27（5）：435-439. doi:10.3969/j.issn.1006-298X.2018.05.007 |
| 32 | 鄢艳， 邹梦林， 黄明俊，等. 自体动静脉内瘘使用寿命的影响因素［J］. 中华肾脏病杂志， 2020，36（4）：300-305. doi:10.3760/cma.j.cn441217-20191007-00057 |
| 33 | YAN Y， YE D， YANG L， et al. A meta-analysis of the association between diabetic patients and AVF failure in dialysis［J］. Ren Fail， 2018，40（1）：379-383. doi:10.1080/0886022x.2018.1456464 |
| 34 | WOODSIDE K J， BELL S， MUKHOPADHYAY P， et al. Arteriovenous Fistula Maturation in Prevalent Hemodialysis Patients in the United States： A National Study［J］. Am J Kidney Dis， 2018，71（6）：793-801. doi:10.1053/j.ajkd.2017.11.020 |
/
| 〈 |
|
〉 |